Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Kidney Neoplasms × Azacitidine × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 61 Myelodysplastic Syndromes 32 Leukemia, Myelomonocytic, Chronic 23 Leukemia 14 Myeloproliferative Disorders 8 Recurrence 7 Lymphoma 7 Neoplasms 6 Hematologic Neoplasms 6 Primary Myelofibrosis 4 Multiple Myeloma 4 Neoplasm, Residual 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Glioblastoma 2 Anemia, Refractory, with Excess of Blasts 2 Thrombocytosis 1 Thrombocythemia, Essential 1 Spinocerebellar Degenerations 1

Interventions

pembrolizumab 6 aldesleukin 6 Cyclophosphamide 6 fludarabine phosphate 5 fludarabine 4 Nivolumab 4 durvalumab 3 Sorafenib 3 Radiotherapy 3 Filgrastim 3 Everolimus 3 Temozolomide 2 Peripheral Blood Stem Cell Transplantation 2 Isotretinoin 2 Interleukin-2 2 Interferon-alpha 2 Fluorouracil 2 Dexamethasone 2 Cyclosporine 2 Bevacizumab 2 vorolanib 1 tremelimumab 1 tocilizumab 1 talazoparib 1 sargramostim 1 poly ICLC 1 palbociclib 1 oblimersen 1 isoquercitrin 1 guadecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00934440 2017-06-14

5-AZ

University of Kansas Medical Center

Phase 1/2 Terminated

11 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡